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Abstract 
A novel G protein-coupled receptor (BDF3) was isolated from bovine genomic DNA by a combined approach of polymerase chain reaction (PCR) 
and hybridization techniques. The predicted amino acid sequence is 317 amino acids in length and displays 80% homology to the human a-MSH 
receptor MCI. Stably transfected into CHO-Kl cells, BDF3 mediates an increase of intracellular CAMP-levels following incubation with NLE-a- 
MSH, a potent a-MSH analog. The stimulation with ACTH,_,, is only moderate and y-MSH is ineffective. Northern blot analysis of bovine tissues 
revealed that the BDF3 gene is higly expressed in the testis as a single 2.3 kb mRNA species, suggesting an involvement of the BDF3 receptor in 
spermatogenesis. 
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1. Introduction 
Proopiomelanocortin (POMC) is a precursor for 
/?-endorphin, ACTH and MSH occurring in the pitui- 
tary, in the brain and in the periphery [l]. Tissue-specific 
proteolytic cleavage of POMC leads to a cell specific 
mixture of bioactive peptides called melanocortins dis- 
playing a wide array of biological effects. Beside the 
known actions on glucocorticoid production in the adre- 
nals and melanocyte growth and pigmentation, melano- 
cortins have been shown to affect learning, attention and 
memory [2], analgesia [3], thermoregulation [4] and re- 
lease of PRL and LH from the pituitary [5]. Little is 
known about the role of melanocortins in the periphery. 
However, melanocortins which have been found in testis 
[6,7] are supposed to act in a paracrine/autocrine way as 
growth factors and to play a role in maintaining testis 
cell function and differentiation [8], MSH and ACTH act 
through G protein-coupled receptors resulting in an in- 
crease of adenylate cyclase activity [9], increase of intra- 
cellular calcium and activation of protein kinase C [lo]. 
Four subtypes (MCI-MC4) belonging to the melano- 
cortin receptor subfamily have been cloned from human 
and mouse tissues [l l-141. However, one or two more 
members of this melanocortin subfamily are predicted 
from Southern blot analysis [l 11. Here we report the 
cloning and stable expression in CHO-Kl cells of the 
bovine melanocortin receptor BDF3 which is expressed 
in large amounts in bovine testis. 
*Corresponding author. Fax: (49) (391) 67 34 40. 
2. Materials and methods 
2.1. Polymerase chain reaction, cloning and sequencing 
Fragments of putative G protein-coupled receptors between trans- 
membrane domain (TM) III and VI were cloned as follows: 100 ng of 
bovine genomic DNA (Stratagene, Heidelberg, Germany) was ampli- 
fied in a total volume of 50 ml containing 50 mM KCI, 10 mM Tris pH 
8.3, 2 mM MgCl,, 200 mM dNTPs, 0.01% gelatine, 25 ng each degen- 
erate primer against TM III and VI [15] and 1 unit Taq I Polymerase 
(Perkin-Elmer, ijberlingen, Germany) by 60 cycles of PCR. Cycles 
conditions were 1 min 30 s 95”C, 2 min 55°C and 3 min 72°C with 
additional 6 s of extention time each cycle of PCR. PCR products were 
purified with Primerase colums (Stratagene), blunted with Klenow 
polymerase and cloned into pBluescriptSK- (Stratagene). Sequencing 
of the cloned DNA was performed by the chain termination method 
[16] with a Sequenase 2.0 kit (USB, Bad Homburg, Germany). 
2.2. Library screening and subcloning 
Clone 517-3 was 3ZP-labelled by the random primer technique [17] 
and used as a probe to screen a bovine genomic library constructed in 
phage ADASH II (Stratagene, Heidelberg, Germany). Hybridization 
conditions were 16 hat 37°C in 20% formamide/ x SSC/S x Denhart’s 
solution/l% SDS and 100 mg/ml salmon sperm DNA. Filters were 
washed 30 min at 42°C in 2 x SSC/l% SDS and 15 min at 60°C in 0.5 x 
SSC/l% SDS. Out of 5 x 10’ phage clones screened, two identical clones 
containing * 20 kb inserts were isolated and verified by Southern blotting 
[18]. The DNA region of interest was subcloned into pBluescriptSK_ 
by a one-step procedure: 500 ng DNA of the genomic clone were 
cleaved with Hind111 together with 250 ng DNA of the recipient vector 
pBluescriptSK_. The enzyme was heat-inactivated at 70°C for 10 min, 
the DNA precipitated, resuspended and ligated o/n at 22°C. Bacterial 
clones containing 1.9 kb Hind111 fragments (pBDF3) were detected by 
hybridization using clone 517-3 as a probe. 
2.3. Stable expression of BDF3 receptors in CHO-Kl cells 
A 1180 bp EcoRUStuI fragment of pBDF3 was subcloned into ex- 
pression vector pcDNA I (Invitrogen, San Diego, USA) at EcoRU 
EcoRV sites. 2 pug of the derived expression plasmid pBDF3-2E was 
contransfected with 0.1 pg of the plasmid pcDNA I neo (Invitrogen) 
into CHO-Kl cells (ATCC, MD, USA)) using Lipofectin (BRL, Eggen- 
stein, Germany). Stable transfectants were selected in NUT-F12 me- 
dium containing 400 @ml G418 (BRL) and 10% foetal calf serum 
(FCS). Clones expressing the highest levels of specific mRNA were 
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selected and tested for CAMP-accumulation following incubation of the 
cells with melanotropic peptides. 
2.4. CAMP assay 
Accumulation of CAMP was measured as follows: 1.5 x lo5 stably 
transfected CHO-Kl cells were seeded in 22 mm twelve-well dishes with 
NUT-F12 medium containing 10% foetal calf serum. The cells were 
then washed twice with serum-free NUT-F12 medium @FM) and pre- 
treated with SFM containing 200 PM isobutyl-methyl-xanthine for 30 
min at 37°C. Thereafter, the melanotropic peptides [N1e4,n-Phe’]-a- 
MSH, I-MSH and ACTH,_,O (Saxon, Hannover, Germany) were 
added in a concentration of 10m6 M and the incubation continued for 
30 min at 37°C. The reaction was terminated by removing the medium, 
scraping and sonicating the cells in 1 ml ice-cold HCl/EtOH (1 vol 1 N 
HCl/lOO vol EtOH). After evaporation of the solution, the residue was 
dissolved in TE buffer and the CAMP content measured by a radioassay 
kit (Amersham, Braunschweig, Germany). 
2.5. RNA preparation and Northern blot analysis 
Total RNA was isolated by the acid guanidinium isothiocyanate 
method [19]. Poly(A) RNA was isolated from total RNA using the 
QuickPrep mRNA purification kit from Pharmacia (Freiburg, Ger- 
many). Aliquots of 10 pug poly(A) RNA were denatured by glyoxal, 
separated by electrophoresis, transferred to Nytran membranes 
(Schleicher and Schuell, Dassel, Germany) and hybridized under high- 
stringency conditions according to standard methods [18] with a 
[‘*P]UTP-labeled cRNA probe transcribed from clone 517-3. Washing 
conditions were 30 min at 50°C in 1 x SSPE/O.l% SDS. Nylon mem- 
branes were exposed to X-ray films for 3-72 h. 
3. Results and discussion 
Bovine genomic DNA was subjected to PCR amplifi- 
cation using degenerate primers to transmembrane do- 
main III and VI of G protein-coupled receptors [15]. 
PCR products were cloned and sequenced. Out of 40 
clones analyzed, clone 517-1 of 450 bp was found to be 
the bovine variant of the orphan receptor dRDC4 previ- 
ously cloned from dog [ 151, and clone 5 17-40 of 500 bp 
was identical to the bovine /3* adrenergic receptor [21]. 
In addition, 9 clones were found to encode fragments of 
novel putative G protein-coupled receptors. 
1 GCTTGGGGCCATGCCTGGGCCGACATT?~CAGCCAGGGAGGGGAGGTG?AGGCCCCTCCCAGGGGAGCCATGAGT~AGCA~ACCCT 91 
M p alg s Q r r LlG S L 14 
GAGAGCAAGCACCCCT-I’CCTCTCCCTGCGGGACG A% CCT GCA CTT GGC TCC CAG AGG CGG CTG CTG GGT TCC CTT 168 
NX c t p p a t 1 p f t L A pNXrtgpqCLe 37 
AAC XC ACG CCC CCA GCC ACC CTC CCC TTC ACC Cn: GCC CCC AAC CGG ACG GGG CCC CAG TGC CTG GAG 231 
vSslDGLFLS*LGLVSLVENVLVV 60 
GTG TCA TCC CTG GAC GGG C’l+Z T’IT C?C AGC C’PG GGG CTG GTG AGT CTC GTG GAG AAC GTG C?G GTA G’X 306 
aaIaKNRNLHSPMyYFICCLAVS 83 
GCT GCC ATT GCC AAG AAC CGC AAC CTG CAC TCC CCC ATG TAC TAC Tl’T ATC ‘XC ‘IGC CTG GCT Gn: XT 375 
DLlVSvsnVLETavmpLLEaGVL 106 
GAC T’PG Cl% Gn: AGC GTC AGC AAC GTG CTG GAG ACG GCA GTC Al-G CCG CTG CTG GAG GCC GGT GTC CTG 444 
atqaAVvQQLDNvTDVllCGsMv 
GCC ACC CAG GCG GCC Gn: G’IG CAG CAG CIY: GAC AAT GTC ATC GAC GM CTC ATC TGC GGA TCC ATG GTG 
129 
513 
S S L C F L G a I A” D R Y IS* I F Y A L R Y 152 
TCC AGC CTC TGC TTC CTG GGT GCC A’I’I GCT G?G GAC CGC TAC ATC TCC ATC TTC TAC GCC CTG CGG TAC 582 
HSvVT+lPRAWRIiaaIWvaSilt 175 
CAC AGT G’IT GTG ACA CTG CCC CGA GCG TGG ACZ ATC ATT GCG GCC ATC TGG G’IG GCC AGC ATC CTC ACC 651 
S 1L F I tY Y n H k viL L C L V gl FiA 198 
AGC CTG CTC TTC A’IC ACC TAC TAC AAC CAC AAG G’IC ATC CTG CTG XX CTC GTT GGC CTC TX ATA GCT 720 
MLaLMAvLYvHMlaRACQHarGI 221 
An: Cn: GCC C’IG ATG GCC G?r CTC TAC GTC CAC AX Cn: GCC CGG GCC TGC CAG CAT GCC CGG GGC ATT 789 
ArLqKRqRpihQGFGLKGAaTLT 244 
GCC CGG CTC CAG AAG AGG CAG CGC CCC ATI CAT CAG GGC ‘ITT GGC CTC AAG GGC GCT GCC ACC CTC ACC 858 
I L L G ” F F L C W G P F F L H L s L I V I. C 267 
ATC CTG C’IG GGC GTC TTC TTC CTC ‘XC ‘XX GGC CCC mC TTC CTG CAC CTC TCG CTC ATC GTC CTC TX 927 
PQHPTCGCIFKNFNLFL~L~I~~ 290 
CCC CAG CAC CCC ACC TGT GGC TGC ATC TTC AAG AAC TTC AX CTC ‘ITC C’TG GCC CTC ATC ATT TGC AAC 996 
a iv D P L I Y A F I S’Q E L R kT’ L Q E V L 313 
GCC ATT GTG GAC CCC CTC ATC TAT GCC TTC CGC AGC CAG GAG CTC CGG AAG ACG CTC CAA GAG GTG CTG 1065 
q c s* W OPA 317 
CAG ‘IGC TCC TGG TGA GGGTGGCAGTGCCGTCGTGTCCCCAGGCCTGTGAGGCCAGGGCAGTCCCTTGACAAAGAGGATCGGCTAG 1151 
ACCATCCCTGAAGGTGAGGGTGCACAGGCCT 1182 
Fig. 1. Nucleotide and predicted amino acid sequence of the EcoRUStuI fragment encoding the bovine receptor BDF3. The presumptive transmem- 
brane domains (I-VII) are underlined and are assigned on the basis of a hydrophobicity plot [271. Amino acid residues of BDF3 that differ from 
human and murine MSH (MCI) receptors [l l] are indicated with small letters. Potential N-linked glycosylation sites at the N-terminal region (N#), 
phosphorylation sites at the C-terminal region and cytoplasmatic loops (S* and T*) and a potential pahnitoylation site at the C-terminus (C) are 
indicated. 
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Fig. 2. Alignment of amino acid sequences of the bovine receptor BDF3 and other members of the melanocortin receptor subfamily cloned from 
man [14]. Identical amino acid residues are boxed. The positions of transmembrane r gions (I-VII) are indicated by bold lines over the sequences. 
One of these fragments, clone 517-3, was used to iso- 
late from a bovine genomic library a 1.9 kb Hind111 
fragment named BDF3 with an open reading frame of 
951 bp encoding a protein of 3 17 amino acids (Fig. 1). 
Hydrophobicity analysis revealed seven highly hydro- 
phobic regions characteristic of G protein-coupled recep- 
tors. The predicted protein contains two potential 
N-linked glycosylation sites (Asn” and Asn29) at the 
N-terminus, seven potential phosphorylation sites [20] at 
the intracellular loops and C-terminus (Ser’l, Ser’45, 
Ser154, Thr15’, Ser302, Thr308 and Ser316) and a conserved 
Cys3’5 at the C-terminus which serves as a potential 
palmytoylation site and probably anchors the C-termi- 
nus at the cell membrane [22]. 
The bovine receptor BDF3 has a very short C-termi- 
nus and lacks some amino acid residues which are con- 
served among most members of the G protein-coupled 
receptors [23]: thus, the cystein residue at the first ex- 
tracellular loop is missing, thought to form a disulfide 
bond with a cystein residue at the second extracellular 
loop; moreover, conserved prolin residues at transmem- 
brane domain (TM) IV and V are missing and the amino 
acid motif NP--Y at TM VII which is strongly conserved 
in all cloned G protein-coupled receptors is replaced by 
the motif DP--Y which occurs also in the human throm- 
bin receptor and the RH3 and RH4 opsins from fruit 
flies [24]. 
A homology search on an EMBL protein database 
reveals the highest similarity of BDF3 to MCl, the 
a-MSH receptor recently isolated from human mela- 
noma cells [11,12], and to the murine MSH-R [l l] indi- 
cating that the bovine receptor BDF3 is closely related 
to this subtype of the melanocortin subfamily. The ho- 
mology between the bovine BDF3 receptor and other 
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Fig. 3. CAMP accumulation in CHO-Kl cells expressing the bovine 
receptor BDF3 following stimulation with melanotropic agonists. Cells 
stably expressing the bovine receptor BDF3 were treated for 30 min 
with serum-free medium containing 200 PM isobutyl-methyl-xanthine 
to inactivate cellular phosphodiesterase activities and CAMP accumula- 
tion was measured in the absence (CON) or presence of 10m6 M mle4,0- 
Phe’]-a-MSH (NLE-a-MSH), I-MSH and ACTH,_,O for a further 30 
min. Values are means of triplicate determinations and expressed in 
percent of control. Wild-type CHO cells did not respond to any of the 
peptides (data not shown). 
members of the human melanocortin family [ 141 is 
weaker, as depicted in Fig. 2. 
Two CHO cell clones, stably expressing high levels of 
BDF3 mRNA were tested for CAMP accumulation fol- 
lowing exposure to melanotropic peptides (Fig. 3). Con- 
sistent with previous reports of cloned human MSH 
receptor stably transfected into HEK 293 cells [I 11, treat- 
ment of transfected cells with 10e6 M [Nle4,D-Phe’]-a- 
MSH [25] a potent a-MSH analog produced a 4,6-fold 
increase of intracellular CAMP level, whereas y-MSH 
was not effective. However, in contrast to the human 
MSH receptor, the elevation of CAMP levels following 
ACTH,_r, was only moderate. Thus, these results, as well 
as the homology to the human a-MSH receptor con&-m 
that BDF3 is a bovine a-MSH receptor. 
abcdefg 
kb 
4.36 
2.32 
1.35 
Fig. 4. Northern blot analysis of receptor BDF3 mRNA in bovine 
tissues. 1Opg aliquots of poly(A) RNA were subjected to electrophore- 
sis, blotted on nylon membranes and hybridized with a 3zP-labelled 
517-3 cRNA probe. (a) kidney (medulla), (b) brain, (c) endometrium 
(day 0), (d) thymus, (e) thyreoidea, (fl testis, (g) corpus luteum. 
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Northern blot analysis revealed that high levels of 
BDF3 mRNA are present in bovine testis, but none in 
kidney (medulla), endometrium, thyreoidea and corpus 
luteum. Faint signals were seen in brain and thymus (Fig. 
4). The occurrence of POMC mRNA and POMC-de- 
rived peptides in testis [6,7] and the ability of ACTHI 
MSH to stimulate cell growth in cultured Sertoli cells 
[26], suggests that melanocortins may be involved in the 
maintenance of spermatogenesis in the adult testis and 
may explain the high level of BDF3 receptor mRNA in 
this tissue. 
In contrast, no transcripts for MSH receptors could be 
detected in human testis [ 111. Future experiments hould 
be done to find out if this reflects a real species-specific 
difference or may be due to age-dependent testicular 
activity. 
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